Atombeat is the global business entity of DP Technology (Deep Potential), delivering AI-driven drug discovery (AIDD) and scientific computing services that replace trial-and-error R&D with first-principles intelligence.
Atombeat is the overseas business entity of DP Technology (Deep Potential), a flagship of the AI For Science paradigm. We apply the Deep Potential method to molecular simulation, free-energy calculation, and compound screening — using AI to replace traditional trial-and-error research.
The result is a dramatic compression of the time and cost required to discover lead compounds, giving pharmaceutical innovators a decisive computational edge from target to candidate.
We have signed with an overseas multinational pharmaceutical company to deliver an integrated AIDD + Research Navigator + CRO solution, with operations spanning Southeast Asia and North America.
One partner across the full pre-clinical journey — from AI-native molecular design to navigated research and validated CRO execution.
AI-driven drug discovery powered by Deep Potential — molecular simulation, free-energy calculation, and large-scale virtual compound screening to surface high-quality candidates fast.
A guided research platform that orchestrates data, models, and decisions across the discovery pipeline — keeping scientific teams aligned from hypothesis to candidate.
End-to-end contract research execution that closes the loop between in-silico prediction and wet-lab validation, delivering a seamless, accountable discovery program.
Deep Potential bridges quantum-mechanical accuracy with the speed of machine learning — turning a slow, empirical search into a directed, computational one.
Build accurate molecular models grounded in first-principles physics.
Run Deep Potential molecular simulation and free-energy calculation at scale.
Screen vast chemical space to rank and prioritize promising compounds.
Confirm leads through CRO wet-lab execution and iterate the loop.
Partnering with pharmaceutical and biotech organizations to bring AI-native discovery to one of the world's fastest-growing life-science regions.
Delivering integrated AIDD, Research Navigator, and CRO programs to established multinational pharmaceutical leaders.